Ngā hua rapu - Naomi I. Maria

  • E whakaatu ana i te 1 - 6 hua o te 6
Whakamahine hua
  1. 1
    Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

    Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? mā M. J. Wahadat, Iris L. A. Bodewes, Naomi I. Maria, Cornelia G van Helden-Meeuwsen, Annette van Dijk-Hummelman, Eline C. Steenwijk, Sylvia Kamphuis, Marjan A. Versnel

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression

    Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression mā Zana Brkić, Naomi I. Maria, Cornelia G van Helden-Meeuwsen, J.P. van de Merwe, Paul Van Daele, Virgil A. S. H. Dalm, Manon E. Wildenberg, Wouter Beumer, Hemmo A. Drexhage, Marjan A. Versnel

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome

    MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome mā Naomi I. Maria, Zana Brkić, Matti Waris, Cornelia G van Helden-Meeuwsen, Kim C. Heezen, J.P. van de Merwe, Paul Van Daele, Virgil A. S. H. Dalm, Hemmo A. Drexhage, Marjan A. Versnel

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity

    Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity mā Iris L. A. Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, Naomi I. Maria, Jessica Tarn, Dennis Lendrem, Marco W.J. Schreurs, Eline C. Steenwijk, Paul Van Daele, Tim Both, Simon Bowman, Bridget Griffiths, Wan‐Fai Ng, Marjan A. Versnel

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm

    Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm mā Sonali Narain, Dimitre G. Stefanov, Alice S. Chau, Andrew G. Weber, Galina Marder, Blanka Kaplan, Prashant Malhotra, Ona Bloom, Audrey Liu, Martin Lesser, Negin Hajizadeh, Stuart L. Cohen, Jennifer Cookingham, David Hirschwerk, Naomi I. Maria, Sanjaya K. Satapathy, Cristina Sison, Matthew D. Taylor, Michael Qiu

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?

    T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus? mā Zana Brkić, Odilia B. J. Corneth, Cornelia G van Helden-Meeuwsen, Radboud J. E. M. Dolhain, Naomi I. Maria, Sandra M. J. Paulissen, Nadine Davelaar, Jan Piet van Hamburg, Paul Van Daele, Virgil A. S. H. Dalm, P. Martin van Hagen, Johanna M. W. Hazes, Marjan A. Versnel, Erik Lubberts

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: